APA (7th ed.) Citation

JA, H., A, A., RA, G., Y, M., C, Z., Y, J., . . . N, S. (2024). Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease. JAMA ophthalmology, 142(8), 750. https://doi.org/10.1001/jamaophthalmol.2024.2376

Chicago Style (17th ed.) Citation

JA, Hallak, et al. "Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease." JAMA Ophthalmology 142, no. 8 (2024): 750. https://doi.org/10.1001/jamaophthalmol.2024.2376.

MLA (9th ed.) Citation

JA, Hallak, et al. "Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease." JAMA Ophthalmology, vol. 142, no. 8, 2024, p. 750, https://doi.org/10.1001/jamaophthalmol.2024.2376.